Ovarian Cancer Debulking Surgery

Ovarian debulking surgery removes visible cancer where possible to support the rest of a person's treatment plan.

It is also called cytoreductive surgery. Cancer may involve the ovaries, fallopian tubes, lining of the abdomen or nearby organs, so the exact operation is planned from imaging, examination findings and what the surgeon sees during surgery.

The procedure is done under general anaesthesia through an abdominal incision. It may include removal of the ovaries, fallopian tubes, uterus, omentum and areas of visible tumour. When cancer involves bowel, bladder surface, diaphragm or other tissues, a specialist may help remove or repair the affected area. The operation is tailored rather than identical for every person.

Abdominal pain, fatigue, nausea, constipation and reduced appetite are common during recovery. If the ovaries are removed before natural menopause, menopausal symptoms can begin abruptly. Serious concerns include fever, a painful swollen leg, chest pain, breathing difficulty, persistent vomiting, wound discharge, increasing abdominal swelling or inability to pass urine or stool; contact the team promptly.

The surgical aim is to remove as much visible disease as is safely possible. The findings help guide the next parts of treatment, which may include systemic therapy. Outcomes are shaped by the cancer type and distribution, response to treatment, general health and whether surgery can be completed safely. Your team can explain what the operative findings mean for your own care.

This is major abdominal surgery and recovery needs practical support. It can affect fertility and trigger menopause when reproductive organs are removed. Before treatment, ask about fertility preservation, symptom control, nutrition and the likely need for additional treatment.

A gynaecological oncology team may recommend debulking surgery for ovarian cancer, fallopian tube cancer or primary peritoneal cancer. It may be offered before systemic treatment or after treatment has reduced disease, depending on the clinical picture. The decision considers where the cancer is, whether complete or substantial removal is feasible and how safely you can undergo surgery.

Before admission, you may have blood tests, imaging, an anaesthetic assessment and medication instructions. On the day, the team confirms the surgical plan and consent. During surgery, removed tissue is assessed by pathology. Afterwards, nurses monitor breathing, circulation, pain, fluids and bowel recovery, and the surgeon updates you or your nominated family member.

Recovery is gradual. Walking short distances as advised helps circulation and bowel function, while heavy lifting waits until the surgical team clears it. Eat and drink according to the plan, take medicines as prescribed, and ask for help with meals, transport and household tasks. Follow-up covers wound healing, pathology and further oncology treatment.

Risks include bleeding, infection, blood clots, reactions to anaesthesia and delayed wound healing. Because this operation may involve abdominal organs, there can be bowel, bladder or ureter injury, a leak after bowel repair, or a need for a temporary or longer-term stoma. The surgeon discusses risks that apply to the planned extent of surgery.

Systemic treatment may be used before surgery when this offers a safer or more effective sequence, or instead of surgery when an operation is unlikely to help or would carry too much risk. Symptom-focused care remains part of treatment at every stage. A specialist team can explain why surgery now, surgery later or non-surgical care is being considered.

Seek a gynaecological oncology service with access to surgeons, anaesthetists, pathology, specialist nurses, dietitians and rehabilitation support. Take imaging reports, medication lists and a support person when possible. Ask who coordinates care if more than one surgical specialty may be involved.